19F-labeled MRI agents (Otsuka Pharma/SUMS)

N/A

Report date: 2025/01/26 18:18:18

Base Information

Drug Name19F-labeled MRI agents (Otsuka Pharma/SUMS)
Drug Alias NameShiga-Y5Shiga-X22XP-7
ClassificationRadiation-emitting products
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShiga University Of Medical ScienceOtsuka Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A